Current management of glaucoma

J Lusthaus, I Goldberg - Medical Journal of Australia, 2019 - Wiley Online Library
Glaucoma is an irreversible progressive optic neuropathy, for which the major proven
treatment is to lower the intraocular pressure (IOP). Five groups of IOP‐lowering eye drops …

[HTML][HTML] Role of adrenergic receptor signalling in neuroimmune communication

S Chhatar, G Lal - Current Research in Immunology, 2021 - Elsevier
Neuroimmune communication plays a crucial role in maintaining homeostasis and promptly
responding to any foreign insults. Sympathetic nerve fibres are innervated into all the …

A review on albumin as a biomaterial for ocular drug delivery

R Tiwari, NK Sethiya, AS Gulbake, NK Mehra… - International Journal of …, 2021 - Elsevier
Abstract Development of ocular drug delivery system is one of the most technically
challenging tasks, when compared with other routes of drug delivery. Eye (an intricate …

[HTML][HTML] Therapeutic drugs and devices for tackling ocular hypertension and glaucoma, and need for neuroprotection and cytoprotective therapies

NA Sharif - Frontiers in pharmacology, 2021 - frontiersin.org
Damage to the optic nerve and the death of associated retinal ganglion cells (RGCs) by
elevated intraocular pressure (IOP), also known as glaucoma, is responsible for visual …

Topical carbonic anhydrase inhibitors and glaucoma in 2021: where do we stand?

A Stoner, A Harris, F Oddone, A Belamkar… - British Journal of …, 2022 - bjo.bmj.com
Carbonic anhydrase inhibitors (CAIs) have been used for many decades in the treatment of
glaucoma. Systemic CAIs were an early treatment option to lower intraocular pressure by …

[HTML][HTML] Ocular surface disease: a known yet overlooked side effect of topical glaucoma therapy

RE Ruiz-Lozano, NS Azar, HM Mousa… - Frontiers in …, 2023 - frontiersin.org
Ocular surface disease (OSD), a disorder affecting the lacrimal and meibomian glands and
the corneal and conjunctival epithelium, is a well-known complication of topical glaucoma …

Advances in the discovery of novel agents for the treatment of glaucoma

F Mincione, A Nocentini, CT Supuran - Expert Opinion on Drug …, 2021 - Taylor & Francis
Introduction Glaucoma, a neuropathy characterized by increased intraocular pressure (IOP),
is the major cause of blindness worldwide and its treatment aims at reducing IOP. Areas …

[HTML][HTML] A narrative review of ocular surface disease related to anti-glaucomatous medications

X Zhou, X Zhang, D Zhou, Y Zhao, X Duan - Ophthalmology and Therapy, 2022 - Springer
Topical anti-glaucomatous medications are still the most important measure to lower
intraocular pressure. Large number of studies have confirmed that long-term use of anti …

[HTML][HTML] Carbonic anhydrase, its inhibitors and vascular function

A García-Llorca, F Carta, CT Supuran… - Frontiers in Molecular …, 2024 - frontiersin.org
It has been known for some time that Carbonic Anhydrase (CA, EC 4.2. 1.1) plays a complex
role in vascular function, and in the regulation of vascular tone. Clinically employed CA …

[HTML][HTML] The management of glaucoma and macular degeneration

CT Supuran - Expert Opinion on Therapeutic Patents, 2019 - Taylor & Francis
Glaucoma [1-8] and macular degeneration [9-11] are among the ophthalmologic diseases
increasingly affecting the aging population worldwide. It is estimated that around 76 million …